Get the Stockscreener App
1.91
7.30%
0.13
Sellas Life Sciences Group Inc stock is traded at $1.91, with a volume of 1.60M.
It is up +7.30% in the last 24 hours and up +17.90% over the past month.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
See More
Previous Close:
$1.78
Open:
$1.78
24h Volume:
1.60M
Relative Volume:
0.63
Market Cap:
$201.12M
Revenue:
-
Net Income/Loss:
$-37.34M
P/E Ratio:
-1.4044
EPS:
-1.36
Net Cash Flow:
$-36.91M
1W Performance:
-0.52%
1M Performance:
+17.90%
6M Performance:
+55.28%
1Y Performance:
+55.28%
1-Day Range:
$1.77
$1.9497
1-Week Range:
$1.75
$1.9505
52-Week Range:
$0.772
$2.2691
Sellas Life Sciences Group Inc Stock (SLS) Company Profile
Name
Sellas Life Sciences Group Inc
Sector
Industry
Phone
(646) 200-5278
Address
7 TIMES SQUARE, NEW YORK, NY
Compare SLS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SLS
Sellas Life Sciences Group Inc
|
1.91 | 187.43M | 0 | -37.34M | -36.91M | -1.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Sellas Life Sciences Group Inc Stock (SLS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-21-21 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-01-18 | Initiated | Oppenheimer | Outperform |
| Apr-02-18 | Initiated | H.C. Wainwright | Buy |
| Mar-19-18 | Upgrade | Maxim Group | Hold → Buy |
Sellas Life Sciences Group Inc Stock (SLS) Latest News
Should you hold or exit SELLAS Life Sciences Group Inc. nowMarket Risk Summary & Safe Capital Growth Trade Ideas - Newser
SELLAS Life Sciences Group Inc. Reversal Rally May Surprise BearsMarket Growth Report & Free Risk Controlled Daily Trade Plans - beatles.ru
Is SELLAS Life Sciences Group Inc. stock heavily shortedQuarterly Trade Summary & AI Driven Stock Reports - خودرو بانک
Is SELLAS Life Sciences Group Inc. a strong growth stockJuly 2025 Action & Accurate Buy Signal Alerts - خودرو بانک
Real time breakdown of SELLAS Life Sciences Group Inc. stock performanceWeekly Investment Recap & Fast Gain Stock Trading Tips - Newser
What’s next for SELLAS Life Sciences Group Inc. stock price2025 Earnings Surprises & Low Risk Entry Point Guides - Newser
Building trade automation scripts for SELLAS Life Sciences Group Inc.2025 Valuation Update & Weekly High Return Opportunities - Newser
Trend analysis for SELLAS Life Sciences Group Inc. this week2025 Sector Review & Technical Confirmation Trade Alerts - Newser
Sentiment analysis tools applied to SELLAS Life Sciences Group Inc.July 2025 Review & Fast Gaining Stock Reports - Newser
Does SELLAS Life Sciences Group Inc. stock benefit from AI growthJuly 2025 Update & Stepwise Trade Signal Guides - خودرو بانک
Is SELLAS Life Sciences Group Inc. still worth holding after the dip2025 Winners & Losers & Daily Profit Focused Screening - Newser
Sector ETF performance correlation with SELLAS Life Sciences Group Inc.Quarterly Trade Summary & Community Consensus Trade Alerts - Newser
What earnings revisions data tells us about SELLAS Life Sciences Group Inc.Sell Signal & Capital Efficiency Focused Ideas - Newser
Price action breakdown for SELLAS Life Sciences Group Inc.July 2025 Patterns & Daily Profit Maximizing Tips - Newser
SELLAS Life Sciences Group Inc. stock daily chart insightsJuly 2025 Market Mood & Risk Managed Investment Strategies - Newser
Is SELLAS Life Sciences Group Inc. stock good for income investorsWeekly Volume Report & AI Driven Stock Reports - خودرو بانک
Has SELLAS Life Sciences Group Inc. formed a bullish divergenceWeekly Trade Report & Precise Swing Trade Entry Alerts - Newser
Real time alert setup for SELLAS Life Sciences Group Inc. performanceQuarterly Trade Report & Proven Capital Preservation Methods - Newser
Should value investors consider SELLAS Life Sciences Group Inc.2025 Bull vs Bear & Detailed Earnings Play Strategies - خودرو بانک
What does recent volatility data suggest for SELLAS Life Sciences Group Inc.2025 Pullback Review & Low Risk Growth Stock Ideas - Newser
What dividend growth rate does SELLAS Life Sciences Group Inc. offerJuly 2025 Review & Verified Trade Idea Suggestions - خودرو بانک
What MACD signals say about SELLAS Life Sciences Group Inc.July 2025 Decliners & Consistent Growth Equity Picks - Newser
How much upside does SELLAS Life Sciences Group Inc. haveMarket Activity Report & Verified Entry Point Detection - خودرو بانک
Intraday Charts Show Spike in SELLAS Life Sciences Group Inc. Activity2025 Fundamental Recap & Consistent Income Trade Recommendations - beatles.ru
What makes SELLAS Life Sciences Group Inc. stock attractive to long term investors2025 Price Action Summary & Safe Entry Trade Reports - Newser
What’s the fair value of SELLAS Life Sciences Group Inc. stockJuly 2025 Trends & Growth Focused Stock Pick Reports - خودرو بانک
Automated trading signals detected on SELLAS Life Sciences Group Inc.Weekly Gains Report & Real-Time Market Sentiment Alerts - Newser
How to forecast SELLAS Life Sciences Group Inc. trends using time series2025 Trading Volume Trends & High Accuracy Swing Entry Alerts - Newser
Will SELLAS Life Sciences Group Inc. Hold Gains Into Close getLinesFromResByArray error: size == 0 - thegnnews.com
Is SELLAS Life Sciences Group Inc. forming a bottoming baseTrade Exit Summary & Technical Confirmation Trade Alerts - Newser
SELLAS Life Sciences Group Inc. Breaks Below Key Support Level getLinesFromResByArray error: size == 0 - 강소기업뉴스
Can SELLAS Life Sciences Group Inc. maintain its current growth rateQuarterly Growth Report & Short-Term High Return Ideas - 선데이타임즈
Published on: 2025-09-02 23:33:47 - Newser
How hedge fund analytics apply to BURU stockGap Up & Safe Entry Trade Signal Reports - Newser
Sellas Life Sciences Group Inc Stock (SLS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):